The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs to Treat Allergic Diseases Market Research Report 2024
Synopsis
Drugs used to treat allergic diseases refer to a class of drugs used to reduce the symptoms of allergic reactions, control inflammatory reactions, or enhance the immune system's tolerance to allergens. These drugs can be used to treat various allergic diseases, including allergic rhinitis, allergic asthma, atopic dermatitis, allergic conjunctivitis, etc. Drugs used to treat allergic diseases can achieve their therapeutic goals through different mechanisms of action. For example, antihistamines can block the effects of histamine, thereby alleviating symptoms; glucocorticoids can inhibit inflammatory responses; immunotherapy can reduce allergic reactions by gradually exposing the body to allergens. The choice of different drugs depends on the severity of the condition, the individual patient's condition, and the goals of treatment.
The global Drugs to Treat Allergic Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Drugs to Treat Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drugs to Treat Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drugs to Treat Allergic Diseases include Mylan, Bayer, UCB Pharma, J&J, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Allergic Diseases.
The Drugs to Treat Allergic Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs to Treat Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs to Treat Allergic Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mylan
Bayer
UCB Pharma
J&J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
Chongqing Huabang Pharmaceutical Co., Ltd.
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs to Treat Allergic Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs to Treat Allergic Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Drugs used to treat allergic diseases refer to a class of drugs used to reduce the symptoms of allergic reactions, control inflammatory reactions, or enhance the immune system's tolerance to allergens. These drugs can be used to treat various allergic diseases, including allergic rhinitis, allergic asthma, atopic dermatitis, allergic conjunctivitis, etc. Drugs used to treat allergic diseases can achieve their therapeutic goals through different mechanisms of action. For example, antihistamines can block the effects of histamine, thereby alleviating symptoms; glucocorticoids can inhibit inflammatory responses; immunotherapy can reduce allergic reactions by gradually exposing the body to allergens. The choice of different drugs depends on the severity of the condition, the individual patient's condition, and the goals of treatment.
The global Drugs to Treat Allergic Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Drugs to Treat Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drugs to Treat Allergic Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Drugs to Treat Allergic Diseases include Mylan, Bayer, UCB Pharma, J&J, Perrigo, GSK, Kaleo, Amneal Pharma, ALK Abello, Aimmune Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Allergic Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Allergic Diseases.
The Drugs to Treat Allergic Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs to Treat Allergic Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs to Treat Allergic Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mylan
Bayer
UCB Pharma
J&J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
Chongqing Huabang Pharmaceutical Co., Ltd.
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs to Treat Allergic Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs to Treat Allergic Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drugs to Treat Allergic Diseases Market Overview
1.1 Product Definition
1.2 Drugs to Treat Allergic Diseases by Type
1.2.1 Global Drugs to Treat Allergic Diseases Market Value Comparison by Type (2024-2030)
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Drugs to Treat Allergic Diseases by Application
1.3.1 Global Drugs to Treat Allergic Diseases Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Drugs to Treat Allergic Diseases Market Size Estimates and Forecasts
1.4.1 Global Drugs to Treat Allergic Diseases Revenue 2019-2030
1.4.2 Global Drugs to Treat Allergic Diseases Sales 2019-2030
1.4.3 Global Drugs to Treat Allergic Diseases Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drugs to Treat Allergic Diseases Market Competition by Manufacturers
2.1 Global Drugs to Treat Allergic Diseases Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drugs to Treat Allergic Diseases Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drugs to Treat Allergic Diseases Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Drugs to Treat Allergic Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Product Type & Application
2.7 Global Key Manufacturers of Drugs to Treat Allergic Diseases, Date of Enter into This Industry
2.8 Global Drugs to Treat Allergic Diseases Market Competitive Situation and Trends
2.8.1 Global Drugs to Treat Allergic Diseases Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs to Treat Allergic Diseases Players Market Share by Revenue
2.8.3 Global Drugs to Treat Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs to Treat Allergic Diseases Market Scenario by Region
3.1 Global Drugs to Treat Allergic Diseases Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drugs to Treat Allergic Diseases Sales by Region: 2019-2030
3.2.1 Global Drugs to Treat Allergic Diseases Sales by Region: 2019-2024
3.2.2 Global Drugs to Treat Allergic Diseases Sales by Region: 2025-2030
3.3 Global Drugs to Treat Allergic Diseases Revenue by Region: 2019-2030
3.3.1 Global Drugs to Treat Allergic Diseases Revenue by Region: 2019-2024
3.3.2 Global Drugs to Treat Allergic Diseases Revenue by Region: 2025-2030
3.4 North America Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.4.1 North America Drugs to Treat Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drugs to Treat Allergic Diseases Sales by Country (2019-2030)
3.4.3 North America Drugs to Treat Allergic Diseases Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.5.1 Europe Drugs to Treat Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drugs to Treat Allergic Diseases Sales by Country (2019-2030)
3.5.3 Europe Drugs to Treat Allergic Diseases Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs to Treat Allergic Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs to Treat Allergic Diseases Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (2019-2030)
3.6.3 Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.7.1 Latin America Drugs to Treat Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drugs to Treat Allergic Diseases Sales by Country (2019-2030)
3.7.3 Latin America Drugs to Treat Allergic Diseases Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drugs to Treat Allergic Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs to Treat Allergic Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs to Treat Allergic Diseases Sales by Type (2019-2030)
4.1.1 Global Drugs to Treat Allergic Diseases Sales by Type (2019-2024)
4.1.2 Global Drugs to Treat Allergic Diseases Sales by Type (2025-2030)
4.1.3 Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2019-2030)
4.2 Global Drugs to Treat Allergic Diseases Revenue by Type (2019-2030)
4.2.1 Global Drugs to Treat Allergic Diseases Revenue by Type (2019-2024)
4.2.2 Global Drugs to Treat Allergic Diseases Revenue by Type (2025-2030)
4.2.3 Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2019-2030)
4.3 Global Drugs to Treat Allergic Diseases Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drugs to Treat Allergic Diseases Sales by Application (2019-2030)
5.1.1 Global Drugs to Treat Allergic Diseases Sales by Application (2019-2024)
5.1.2 Global Drugs to Treat Allergic Diseases Sales by Application (2025-2030)
5.1.3 Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2019-2030)
5.2 Global Drugs to Treat Allergic Diseases Revenue by Application (2019-2030)
5.2.1 Global Drugs to Treat Allergic Diseases Revenue by Application (2019-2024)
5.2.2 Global Drugs to Treat Allergic Diseases Revenue by Application (2025-2030)
5.2.3 Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2019-2030)
5.3 Global Drugs to Treat Allergic Diseases Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Company Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan Drugs to Treat Allergic Diseases Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Drugs to Treat Allergic Diseases Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 UCB Pharma
6.3.1 UCB Pharma Company Information
6.3.2 UCB Pharma Description and Business Overview
6.3.3 UCB Pharma Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.3.4 UCB Pharma Drugs to Treat Allergic Diseases Product Portfolio
6.3.5 UCB Pharma Recent Developments/Updates
6.4 J&J
6.4.1 J&J Company Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J&J Drugs to Treat Allergic Diseases Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Perrigo
6.5.1 Perrigo Company Information
6.5.2 Perrigo Description and Business Overview
6.5.3 Perrigo Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Perrigo Drugs to Treat Allergic Diseases Product Portfolio
6.5.5 Perrigo Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Drugs to Treat Allergic Diseases Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Kaleo
6.7.1 Kaleo Company Information
6.7.2 Kaleo Description and Business Overview
6.7.3 Kaleo Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Kaleo Drugs to Treat Allergic Diseases Product Portfolio
6.7.5 Kaleo Recent Developments/Updates
6.8 Amneal Pharma
6.8.1 Amneal Pharma Company Information
6.8.2 Amneal Pharma Description and Business Overview
6.8.3 Amneal Pharma Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amneal Pharma Drugs to Treat Allergic Diseases Product Portfolio
6.8.5 Amneal Pharma Recent Developments/Updates
6.9 ALK Abello
6.9.1 ALK Abello Company Information
6.9.2 ALK Abello Description and Business Overview
6.9.3 ALK Abello Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ALK Abello Drugs to Treat Allergic Diseases Product Portfolio
6.9.5 ALK Abello Recent Developments/Updates
6.10 Aimmune Therapeutics
6.10.1 Aimmune Therapeutics Company Information
6.10.2 Aimmune Therapeutics Description and Business Overview
6.10.3 Aimmune Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aimmune Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.10.5 Aimmune Therapeutics Recent Developments/Updates
6.11 Chongqing Huabang Pharmaceutical Co., Ltd.
6.11.1 Chongqing Huabang Pharmaceutical Co., Ltd. Company Information
6.11.2 Chongqing Huabang Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Product Portfolio
6.11.5 Chongqing Huabang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Allergy Therapeutics
6.12.1 Allergy Therapeutics Company Information
6.12.2 Allergy Therapeutics Description and Business Overview
6.12.3 Allergy Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Allergy Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.12.5 Allergy Therapeutics Recent Developments/Updates
6.13 ASIT Biotech
6.13.1 ASIT Biotech Company Information
6.13.2 ASIT Biotech Description and Business Overview
6.13.3 ASIT Biotech Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ASIT Biotech Drugs to Treat Allergic Diseases Product Portfolio
6.13.5 ASIT Biotech Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sanofi Drugs to Treat Allergic Diseases Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 DBV Technologies
6.15.1 DBV Technologies Company Information
6.15.2 DBV Technologies Description and Business Overview
6.15.3 DBV Technologies Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.15.4 DBV Technologies Drugs to Treat Allergic Diseases Product Portfolio
6.15.5 DBV Technologies Recent Developments/Updates
6.16 HAL Allergy
6.16.1 HAL Allergy Company Information
6.16.2 HAL Allergy Description and Business Overview
6.16.3 HAL Allergy Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.16.4 HAL Allergy Drugs to Treat Allergic Diseases Product Portfolio
6.16.5 HAL Allergy Recent Developments/Updates
6.17 Intrommune Therapeutics
6.17.1 Intrommune Therapeutics Company Information
6.17.2 Intrommune Therapeutics Description and Business Overview
6.17.3 Intrommune Therapeutics Drugs to Treat Allergic Diseases Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Intrommune Therapeutics Drugs to Treat Allergic Diseases Product Portfolio
6.17.5 Intrommune Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs to Treat Allergic Diseases Industry Chain Analysis
7.2 Drugs to Treat Allergic Diseases Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs to Treat Allergic Diseases Production Mode & Process
7.4 Drugs to Treat Allergic Diseases Sales and Marketing
7.4.1 Drugs to Treat Allergic Diseases Sales Channels
7.4.2 Drugs to Treat Allergic Diseases Distributors
7.5 Drugs to Treat Allergic Diseases Customers
8 Drugs to Treat Allergic Diseases Market Dynamics
8.1 Drugs to Treat Allergic Diseases Industry Trends
8.2 Drugs to Treat Allergic Diseases Market Drivers
8.3 Drugs to Treat Allergic Diseases Market Challenges
8.4 Drugs to Treat Allergic Diseases Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Drugs to Treat Allergic Diseases Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drugs to Treat Allergic Diseases Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Drugs to Treat Allergic Diseases Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drugs to Treat Allergic Diseases Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drugs to Treat Allergic Diseases Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drugs to Treat Allergic Diseases Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drugs to Treat Allergic Diseases Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drugs to Treat Allergic Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Drugs to Treat Allergic Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs to Treat Allergic Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Allergic Diseases as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs to Treat Allergic Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drugs to Treat Allergic Diseases Sales by Region (2019-2024) & (K Units)
Table 18. Global Drugs to Treat Allergic Diseases Sales Market Share by Region (2019-2024)
Table 19. Global Drugs to Treat Allergic Diseases Sales by Region (2025-2030) & (K Units)
Table 20. Global Drugs to Treat Allergic Diseases Sales Market Share by Region (2025-2030)
Table 21. Global Drugs to Treat Allergic Diseases Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drugs to Treat Allergic Diseases Revenue Market Share by Region (2019-2024)
Table 23. Global Drugs to Treat Allergic Diseases Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drugs to Treat Allergic Diseases Revenue Market Share by Region (2025-2030)
Table 25. North America Drugs to Treat Allergic Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drugs to Treat Allergic Diseases Sales by Country (2019-2024) & (K Units)
Table 27. North America Drugs to Treat Allergic Diseases Sales by Country (2025-2030) & (K Units)
Table 28. North America Drugs to Treat Allergic Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drugs to Treat Allergic Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drugs to Treat Allergic Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drugs to Treat Allergic Diseases Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drugs to Treat Allergic Diseases Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drugs to Treat Allergic Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drugs to Treat Allergic Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drugs to Treat Allergic Diseases Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drugs to Treat Allergic Diseases Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drugs to Treat Allergic Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drugs to Treat Allergic Diseases Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drugs to Treat Allergic Diseases Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drugs to Treat Allergic Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drugs to Treat Allergic Diseases Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Drugs to Treat Allergic Diseases Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Drugs to Treat Allergic Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drugs to Treat Allergic Diseases Sales (K Units) by Type (2019-2024)
Table 51. Global Drugs to Treat Allergic Diseases Sales (K Units) by Type (2025-2030)
Table 52. Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2019-2024)
Table 53. Global Drugs to Treat Allergic Diseases Sales Market Share by Type (2025-2030)
Table 54. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2019-2024)
Table 57. Global Drugs to Treat Allergic Diseases Revenue Market Share by Type (2025-2030)
Table 58. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drugs to Treat Allergic Diseases Sales (K Units) by Application (2019-2024)
Table 61. Global Drugs to Treat Allergic Diseases Sales (K Units) by Application (2025-2030)
Table 62. Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2019-2024)
Table 63. Global Drugs to Treat Allergic Diseases Sales Market Share by Application (2025-2030)
Table 64. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drugs to Treat Allergic Diseases Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2019-2024)
Table 67. Global Drugs to Treat Allergic Diseases Revenue Market Share by Application (2025-2030)
Table 68. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2025-2030)
Table 70. Mylan Company Information
Table 71. Mylan Description and Business Overview
Table 72. Mylan Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Mylan Drugs to Treat Allergic Diseases Product
Table 74. Mylan Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Drugs to Treat Allergic Diseases Product
Table 79. Bayer Recent Developments/Updates
Table 80. UCB Pharma Company Information
Table 81. UCB Pharma Description and Business Overview
Table 82. UCB Pharma Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. UCB Pharma Drugs to Treat Allergic Diseases Product
Table 84. UCB Pharma Recent Developments/Updates
Table 85. J&J Company Information
Table 86. J&J Description and Business Overview
Table 87. J&J Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. J&J Drugs to Treat Allergic Diseases Product
Table 89. J&J Recent Developments/Updates
Table 90. Perrigo Company Information
Table 91. Perrigo Description and Business Overview
Table 92. Perrigo Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Perrigo Drugs to Treat Allergic Diseases Product
Table 94. Perrigo Recent Developments/Updates
Table 95. GSK Company Information
Table 96. GSK Description and Business Overview
Table 97. GSK Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GSK Drugs to Treat Allergic Diseases Product
Table 99. GSK Recent Developments/Updates
Table 100. Kaleo Company Information
Table 101. Kaleo Description and Business Overview
Table 102. Kaleo Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Kaleo Drugs to Treat Allergic Diseases Product
Table 104. Kaleo Recent Developments/Updates
Table 105. Amneal Pharma Company Information
Table 106. Amneal Pharma Description and Business Overview
Table 107. Amneal Pharma Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Amneal Pharma Drugs to Treat Allergic Diseases Product
Table 109. Amneal Pharma Recent Developments/Updates
Table 110. ALK Abello Company Information
Table 111. ALK Abello Description and Business Overview
Table 112. ALK Abello Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. ALK Abello Drugs to Treat Allergic Diseases Product
Table 114. ALK Abello Recent Developments/Updates
Table 115. Aimmune Therapeutics Company Information
Table 116. Aimmune Therapeutics Description and Business Overview
Table 117. Aimmune Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Aimmune Therapeutics Drugs to Treat Allergic Diseases Product
Table 119. Aimmune Therapeutics Recent Developments/Updates
Table 120. Chongqing Huabang Pharmaceutical Co., Ltd. Company Information
Table 121. Chongqing Huabang Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Chongqing Huabang Pharmaceutical Co., Ltd. Drugs to Treat Allergic Diseases Product
Table 124. Chongqing Huabang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 125. Allergy Therapeutics Company Information
Table 126. Allergy Therapeutics Description and Business Overview
Table 127. Allergy Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Allergy Therapeutics Drugs to Treat Allergic Diseases Product
Table 129. Allergy Therapeutics Recent Developments/Updates
Table 130. ASIT Biotech Company Information
Table 131. ASIT Biotech Description and Business Overview
Table 132. ASIT Biotech Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ASIT Biotech Drugs to Treat Allergic Diseases Product
Table 134. ASIT Biotech Recent Developments/Updates
Table 135. Sanofi Company Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sanofi Drugs to Treat Allergic Diseases Product
Table 139. Sanofi Recent Developments/Updates
Table 140. DBV Technologies Company Information
Table 141. DBV Technologies Description and Business Overview
Table 142. DBV Technologies Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. DBV Technologies Drugs to Treat Allergic Diseases Product
Table 144. DBV Technologies Recent Developments/Updates
Table 145. HAL Allergy Company Information
Table 146. HAL Allergy Description and Business Overview
Table 147. HAL Allergy Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. HAL Allergy Drugs to Treat Allergic Diseases Product
Table 149. HAL Allergy Recent Developments/Updates
Table 150. Intrommune Therapeutics Company Information
Table 151. Intrommune Therapeutics Description and Business Overview
Table 152. Intrommune Therapeutics Drugs to Treat Allergic Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Intrommune Therapeutics Drugs to Treat Allergic Diseases Product
Table 154. Intrommune Therapeutics Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Drugs to Treat Allergic Diseases Distributors List
Table 158. Drugs to Treat Allergic Diseases Customers List
Table 159. Drugs to Treat Allergic Diseases Market Trends
Table 160. Drugs to Treat Allergic Diseases Market Drivers
Table 161. Drugs to Treat Allergic Diseases Market Challenges
Table 162. Drugs to Treat Allergic Diseases Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs to Treat Allergic Diseases
Figure 2. Global Drugs to Treat Allergic Diseases Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drugs to Treat Allergic Diseases Market Share by Type: 2023 & 2030
Figure 4. Epinephrine Injection Product Picture
Figure 5. Antihistamines Product Picture
Figure 6. Oral Immunotherapy Product Picture
Figure 7. Other Product Picture
Figure 8. Global Drugs to Treat Allergic Diseases Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Drugs to Treat Allergic Diseases Market Share by Application: 2023 & 2030
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Global Drugs to Treat Allergic Diseases Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drugs to Treat Allergic Diseases Market Size (2019-2030) & (US$ Million)
Figure 15. Global Drugs to Treat Allergic Diseases Sales (2019-2030) & (K Units)
Figure 16. Global Drugs to Treat Allergic Diseases Average Price (US$/Unit) & (2019-2030)
Figure 17. Drugs to Treat Allergic Diseases Report Years Considered
Figure 18. Drugs to Treat Allergic Diseases Sales Share by Manufacturers in 2023
Figure 19. Global Drugs to Treat Allergic Diseases Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Drugs to Treat Allergic Diseases Players: Market Share by Revenue in Drugs to Treat Allergic Diseases in 2023
Figure 21. Drugs to Treat Allergic Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Drugs to Treat Allergic Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Drugs to Treat Allergic Diseases Sales Market Share by Country (2019-2030)
Figure 24. North America Drugs to Treat Allergic Diseases Revenue Market Share by Country (2019-2030)
Figure 25. United States Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Drugs to Treat Allergic Diseases Sales Market Share by Country (2019-2030)
Figure 28. Europe Drugs to Treat Allergic Diseases Revenue Market Share by Country (2019-2030)
Figure 29. Germany Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Drugs to Treat Allergic Diseases Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Drugs to Treat Allergic Diseases Revenue Market Share by Region (2019-2030)
Figure 36. China Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Drugs to Treat Allergic Diseases Sales Market Share by Country (2019-2030)
Figure 44. Mexico Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Drugs to Treat Allergic Diseases Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Drugs to Treat Allergic Diseases Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Drugs to Treat Allergic Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Drugs to Treat Allergic Diseases by Type (2019-2030)
Figure 54. Global Revenue Market Share of Drugs to Treat Allergic Diseases by Type (2019-2030)
Figure 55. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Drugs to Treat Allergic Diseases by Application (2019-2030)
Figure 57. Global Revenue Market Share of Drugs to Treat Allergic Diseases by Application (2019-2030)
Figure 58. Global Drugs to Treat Allergic Diseases Price (US$/Unit) by Application (2019-2030)
Figure 59. Drugs to Treat Allergic Diseases Value Chain
Figure 60. Drugs to Treat Allergic Diseases Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
